Should nurses have access to rocuronium (ROC) and succinylcholine (SCC)?

Should Nurses Have Access to Rocuronium and Succinylcholine?

No, nurses should not have independent access to rocuronium and succinylcholine—these neuromuscular blocking agents must only be administered by clinicians specifically trained in advanced airway management with immediate capability for tracheal intubation and mechanical ventilation.

Critical Safety Requirements

Both medications cause complete paralysis and respiratory arrest, requiring immediate airway control. The FDA label for succinylcholine explicitly states it "should be used only by those skilled in the management of artificial respiration and only when facilities are instantly available for tracheal intubation and for providing adequate ventilation" 1. This same principle applies to rocuronium 2.

Who Should Administer These Medications

Personnel qualified to administer rocuronium and succinylcholine must:

• Possess advanced airway management skills (laryngoscopy, intubation, surgical airway)
• Have immediate access to intubation equipment and mechanical ventilation
• Be trained to manage complications including:
  • Cannot intubate, cannot oxygenate (CICO) scenarios
  • Malignant hyperthermia
  • Severe hyperkalemia
  • Anaphylaxis
  • Cardiovascular collapse

The 2025 Difficult Airway Society guidelines emphasize that neuromuscular blockade "improves the likelihood of successful tracheal intubation, SAD ventilation, facemask ventilation, and eFONA" but requires expert management throughout 3.

Institutional Framework for Access

Appropriate Access Models

In emergency settings, these medications should be:

1. Stored in controlled locations (operating rooms, emergency departments, ICUs)
2. Administered only during rapid sequence intubation by physicians, nurse anesthetists (CRNAs), or anesthesiologist assistants
3. Part of a complete airway management protocol including pre-oxygenation, induction agents, monitoring, and reversal agents 4

Critical Safeguards

The FDA specifically warns about "Risk of Death due to Medication Errors" with succinylcholine, noting that "administration results in paralysis, which may lead to respiratory arrest and death; this progression may be more likely to occur in a patient for whom it is not intended" 1. This underscores why access must be restricted to qualified providers.

Clinical Context

When These Medications Are Used

Current guidelines recommend neuromuscular blocking agents for:

• Rapid sequence intubation in critically ill patients 5
• Emergency airway management including laryngospasm 6
• Facilitating intubation to improve first-pass success 3, 7

The 2023 Society of Critical Care Medicine guidelines suggest "administering either rocuronium or succinylcholine for RSI when there are no known contraindications to succinylcholine" 5, but this recommendation assumes administration by appropriately trained clinicians.

Monitoring Requirements

Essential monitoring during neuromuscular blockade includes:

• Continuous pulse oximetry and capnography 3
• Quantitative neuromuscular monitoring when feasible 3
• Immediate availability of reversal agents (sugammadex for rocuronium) 8, 5
• Vasopressors for hemodynamic instability 4

Special Considerations

Pediatric Patients

In pediatric settings, succinylcholine use "should be reserved for emergency intubation or instances where immediate securing of the airway is necessary" due to risk of hyperkalemia and cardiac arrest 1. This further emphasizes the need for expert administration.

Risk of Awareness

The longer duration of rocuronium (30-60 minutes) compared to succinylcholine (5-10 minutes) creates risk of patient awareness if post-intubation sedation is delayed 5. This requires coordinated team management beyond the scope of independent nursing practice.

Common Pitfalls to Avoid

1. Assuming paralysis equals unconsciousness: These agents provide no sedation, analgesia, or amnesia 9
2. Inadequate preparation: Equipment for bag-mask ventilation, intubation, and surgical airway must be immediately available 1
3. Delayed post-intubation sedation: Particularly with rocuronium, which may mask inadequate sedation 5
4. Contraindications to succinylcholine: Hyperkalemia risk in burns, trauma, denervation, neuromuscular disease 1

The fundamental principle is that neuromuscular blocking agents should only be accessible to providers with comprehensive airway management training and immediate capability to secure the airway and provide mechanical ventilation.